Exclusion by Design: Enrollment Criteria Limit Older Adult Participation in SARS-CoV-2 Vaccine Clinical Trials
{{output}}
Background and objectives: Older adults (≥65 years) face a disproportionate burden of COVID-19 mortality yet remain underrepresented in clinical trials despite this group accounting for 76% of COVID-19 deaths. Hundreds of SARS-C... ...
